https://scholars.lib.ntu.edu.tw/handle/123456789/454774
標題: | Structure-based design, synthesis and biological evaluation of novel anthra[1,2-d]imidazole-6,11-dione homologues as potential antitumor agents | 作者: | Chen T.-C. Yu D.-S. Huang K.-F. Fu Y.-C. Lee C.-C. Chen C.-L. Huang F.-C. Hsieh H.-H. JING-JER LIN Huang H.-S. |
關鍵字: | Anthra 12-dimidazole-611-dione; Cytostatic and cytotoxic activities; NCI 60-cell panel assay; Selectivity ratio | 公開日期: | 2013 | 卷: | 69 | 起(迄)頁: | 278-293 | 來源出版物: | European Journal of Medicinal Chemistry | 摘要: | By using fragment-based design strategies, a series of 2-thio-substituted anthra[1,2-d]imidazole-6,11-diones were synthesized and evaluated for hTERT repressing activities, cell proliferations, and NCI 60-cell panel assay. Compounds 2, 3, 4, 11, 15 and 35 were selected by the NCI and 3, 4, 11 and 15 represent the GI50, TGI and LC50, respectively. Among them, all were moderate selectivity toward leukemia cancer except for 4 exhibited distinctive selectivity of CNS and renal cancer with 7.403 and 6.475. The overall of test compounds exhibited different cytostatic and cytotoxic activities for further developing potential application as anticancer drugs. ? 2013 Published by Elsevier Masson SAS. All rights reserved. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84883877783&doi=10.1016%2fj.ejmech.2013.06.058&partnerID=40&md5=dc8b6cb44a26ee3a925a3d71cda4550c https://scholars.lib.ntu.edu.tw/handle/123456789/454774 |
ISSN: | 0223-5234 | DOI: | 10.1016/j.ejmech.2013.06.058 | SDG/關鍵字: | 2 ((2 (pyrrolidin 1 yl)ethyl)thio) 1h anthra[1,2 d] imidazole 6,11 dione; 2 ((3 (dimethylamino)propyl)thio) 1h anthra[1,2 d] imidazole 6,11 dione; 2 (ethylthio) 1h anthra[1,2 d]imidazole 6,11 dione; 2 (propylthio) 1h anthra[1,2 d]imidazole 6,11 dione; 2 mercapto 1(3)h anthra[1,2 d] imidazole 6,11 dion; 2 thioxo 2,3 dihydro 1h anthra[1,2 d]imidazole 6,11 dione; antineoplastic agent; unclassified drug; antineoplastic activity; article; breast cancer; cancer cell culture; cell proliferation; cell viability; central nervous system tumor; colon cancer; controlled study; cytostasis; cytotoxicity; drug design; drug structure; drug synthesis; gene repression; human; human cell; human cell culture; in vitro study; kidney cancer; LC 50; leukemia; lung non small cell cancer; melanoma; ovary cancer; prostate cancer; substitution reaction; Anthra[1,2-d]imidazole-6,11-dione; Cytostatic and cytotoxic activities; NCI 60-cell panel assay; Selectivity ratio; Anthraquinones; Antineoplastic Agents; Benzimidazoles; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Heterocyclic Compounds with 4 or More Rings; Humans; Molecular Structure; Structure-Activity Relationship; Telomerase |
顯示於: | 生物化學暨分子生物學科研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。